Cart
sales@molnova.com
αvβ1 integrin-IN-1
CAS No. 1689540-62-2
αvβ1 integrin-IN-1( —— )
Catalog No. M33190 CAS No. 1689540-62-2
αvβ1 integrin-IN-1 is a potent and selective inhibitor of αvβ1 integrin (IC50 of 0.63 nM) with antifibrotic effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 337 | In Stock |
|
| 5MG | 275 | In Stock |
|
| 10MG | 432 | In Stock |
|
| 25MG | 696 | In Stock |
|
| 50MG | 918 | In Stock |
|
| 100MG | 1265 | In Stock |
|
| 200MG | 1702 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Nameαvβ1 integrin-IN-1
-
NoteResearch use only, not for human use.
-
Brief Descriptionαvβ1 integrin-IN-1 is a potent and selective inhibitor of αvβ1 integrin (IC50 of 0.63 nM) with antifibrotic effects.
-
Descriptionαvβ1 integrin-IN-1 (Compound C8) is a potent and selective αvβ1 integrin inhibitor with an IC50 of 0.63 nM. Antifibrotic effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1689540-62-2
-
Formula Weight558.65
-
Molecular FormulaC26H34N6O6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(=O)(=O)(N1[C@H](C(N[C@@H](CC2=CC=C(NC(CCCCNC(=N)N)=O)C=C2)C(O)=O)=O)CCC1)C3=CC=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Reed NI, et al. Exploring N-Arylsulfonyl-l-proline Scaffold as a Platform for Potent and Selective αvβ1 Integrin Inhibitors. ACS Med Chem Lett. 2016 Aug 30;7(10):902-907.?
molnova catalog
related products
-
Lifitegrast sodium
Lifitegrast sodium (SAR-1118-023 sodium) is a small molecule integrin antagonist that inhibits T cell-mediated inflammation by blocking the binding of two important cell surface proteins (lymphocyte function-associated antigen 1 and intercellular adhesion molecule 1), which reduces inflammation of the ocular surface, and may be used in the study of dry eye.
-
GSK-3008348
GSK-3008348 is a novel potent, selective integrin αvβ6 antagonist for the treatment of idiopathic pulmonary fibrosis (IPF).
-
OSU-T315
A novel potent, orally active ILK (integrin-linked kinase) inhibitor with IC50 of 0.6 uM.
